Toxicity of ethylene combustion condensates is directly proportional to their carbon content.

Numerous epidemiological studies have shown a strong link between air pollution and human morbidity and mortality. Combustion sources are most significant contributors to the urban air pollution. So far, toxicological research has focused predominantly on combustion generated particulate matter, thereby neglecting chemical complexity of combustion exhausts. The aim of this study was to assess toxic potential of ethylene combustion condensates, containing both particulate and gaseous combustion by-products, by means of a recombinant bacterial assay called the SWITCH (Salmonella Weighting of Induced Toxicity (Genotoxicity) and Cytotoxicity for Human Health) test. Thereby, the suitability of total organic carbon (TOC) as a parameter for toxicity assessment was also investigated. Ethylene was combusted in a low-pressure burner under controlled laboratory conditions by only varying the carbon/oxygen ratio (C/O=0.63-0.93). Ethylene combustion condensates were generated by drawing 10 l of combustion exhaust at constant flow rate (0.4 l/min) and collecting it in condensated form in glass bottles cooled by liquid nitrogen. Genotoxic and cytotoxic potency of combustion condensates was analyzed with the SWITCH test, based on sequential measurements of luminescence, absorbance and fluorescence outputs of treated bacterial cultures. Our results show correlation between TOC content of combustion condensates and their genotoxicity/cytotoxicity. Moreover, combustion condensates of same TOC concentration exert the same toxic effect regardless of the used C/O ratios during their generation. Our results revealed that toxicologically relevant component(s) of the ethylene combustion exhausts is/are being produced during highly, mildly and non-sooting combustion conditions, only in different proportions. Thereby, total organic carbon proved to be a suitable parameter for the assessment of the toxicity of combustion condensates.

The SOS-LUX-TOXICITY-Test on the International Space Station.

For the safety of astronauts and to ensure the stability and integrity of the genome of microorganisms and plants used in bioregenerative life support systems, it is important to improve our knowledge of the combined action of (space) radiation and microgravity. The SOS-LUX-TOXICITY test, as part of the TRIPLE-LUX project (accepted for flight at Biolab in Columbus on the International Space Station, (ISS)), will provide an estimation of the health risk resulting from exposure of astronauts to the radiation environment of space in microgravity. The project will: (i) increase our knowledge of biological/health threatening action of space radiation and enzymatic DNA repair; (ii) uncover cellular mechanisms of synergistic interaction of microgravity and space radiation; (iii) provide specified biosensors for spacecraft milieu examination; and (iv) provide experimental data on stability and integrity of bacterial DNA in spacecrafts. In the bacterial biosensor "SOS-LUX-Test" developed at DLR (patent), bacteria are transformed with the pBR322-derived plasmid pPLS-1 or the similar, advanced plasmid SWITCH, both carrying the promoterless lux operon of Photobacterium leiognathi as the reporter element controlled by a DNA damage-dependent SOS promoter as sensor element. A short description of the space experiment is given, and the current status of adaptation of the SOS-LUX-Test to the ISS, i.e. first results of sterilization, biocompatibility and functional tests performed with the already available hardware and bread board model of the automated space hardware under development, is described here.

Gene expression modulation in A549 human lung cells in response to combustion-generated nano-sized particles.

High levels of ambient air pollution are associated in humans with aggravation of asthma and of respiratory and cardiopulmonary morbidity; long-term exposures to particulate matter (PM) have been linked to possible increases in lung cancer risk, chronic respiratory disease, and increased death rates. The Biodiagnostics Group of the DLR Institute of Aerospace Medicine develops cellular test systems capable of monitoring the biological consequences of environmental conditions on humans already on cellular and molecular level. Such bioassays rely on the receptor-reporter principle, where cell lines are transfected with plasmids carrying a reporter gene under control of environment-dependent promoters (receptor), which play a key role in regulating gene expressions in response to extracellular signals. We developed the recombinant human lung epithelial cell line A549-NF-kappaB-EGFP/Neo carrying a genetically encoded fluorescent indicator for monitoring activation of the NF-kappaB signaling pathway in living cells in response to genotoxic and cytotoxic environmental influences. With this cell line we screened several candidate human radiation-responsive genes (GADD45beta, CDKN1A) and NF-kappaB-dependent genes (IL-6, NFkappaBIA, and pNF-kappaB-EGFP) for gene expression changes by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assay, using cDNA obtained from total RNA isolated at various time points after exposure to combustion generated nano-sized particle samples.